NIH-funded research R01 grant

Investigating calcium entry's role in nerve damage after spinal cord injury

Official title: The role of SOCE in microglia and secondary degeneration after SCI

Funded at University of Louisville · NIH-11001949 · Data updated 2026-11-12

This study is looking at how a process called store-operated calcium entry affects nerve and immune cells after spinal cord injuries, with the goal of finding new ways to help improve recovery for people who have experienced these injuries.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Louisville
NIH-funded
Lab location1 site (Louisville, United States)
Project startFebruary 1, 2023
Project endDecember 31, 2027
Funding year2025
Award (this year)$414,535
NIH project number5R01NS129987-03
Project IDNIH-11001949 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have experienced a spinal cord injury and are facing challenges related to nerve damage and recovery.

Less likely to help

Patients with spinal cord injuries that are too severe or those who have already undergone extensive treatment may not benefit from this research.

What this research studies

This research focuses on understanding how store-operated calcium entry (SOCE) affects nerve cells and immune cells called microglia after spinal cord injuries. By using specific genetic modifications, the study aims to determine how SOCE contributes to secondary degeneration of nerve tissue, which can worsen recovery. The researchers will explore the mechanisms behind calcium overload and its impact on inflammation and nerve function, potentially leading to new therapeutic strategies for improving recovery after spinal cord injuries.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve recovery and neurological outcomes for patients with spinal cord injuries.

How similar studies have gone: While the role of calcium in nerve injury is established, the specific focus on SOCE in this context is relatively novel and has not been extensively tested in prior studies.

Where this research is happening

  • University of Louisville
    Louisville, United States
    Active

Researchers

  • Principal investigator: Stirling, David Paul — University of Louisville
  • Study coordinator: Stirling, David Paul

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.